Xiaoshuang Niu

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy

Youmei Xiao, Zhuoying He, Wanqiong Li et al. · Nature Communications · 2025 · 54 citations · Full text

Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy

Xin Yang, Wanqiong Li, Shuzhen Li et al. · Journal of Controlled Release · 2023 · 33 citations

Medicine, Peptide Engineering, Immunology +7

Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy

Zheng Hu, Wanqiong Li, Shaomeng Chen et al. · Science China Life Sciences · 2023 · 31 citations

Tumor Immunology, Peptide Engineering, Novel Chimeric Peptide +10

Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy

Yuzhen Qian, Yixuan Sun, Peishang Shi et al. · Acta Pharmaceutica Sinica B · 2023 · 22 citations · Full text

Identification of a novel small-molecule inhibitor targeting TIM-3 for cancer immunotherapy

Menghan Wu, Aijun Wu, Xiangrui Zhang et al. · Biochemical Pharmacology · 2023 · 15 citations

Cancer Immunosurveillance, Novel Therapy, Medicine +8